Diagnosis of leishmaniasis
Metadatos
Mostrar el registro completo del ítemAutor
Kotb Abd Elghany Elmahallawy, Ehab; Sampedro Martínez, Antonio; Rodríguez Granger, Javier; Hoyos Mallecot, Yannick; Agil Abdalla, Mhmad Ahmad; Navarro-Marí, José María; Gutiérrez Fernández, JoséEditorial
The Journal of Infection in Developing Countries
Materia
Leishmaniasis Diagnosis Serology HIV co-infection
Fecha
2014-08Referencia bibliográfica
Elmahallawy, E. K., Martínez, A. S., Rodriguez-Granger, J., Hoyos-Mallecot, Y., Agil, A., Mari, J. M. N., & Fernández, J. G. (2014). Diagnosis of leishmaniasis. The Journal of Infection in Developing Countries, 8(08), 961-972. [doi:10.3855/jidc.4310]
Patrocinador
Erasmus Mundus Scholarship Programme (ELEMENT Action 1 First call) 736Resumen
Leishmaniasis is a clinically heterogeneous syndrome caused by intracellular protozoan parasites of the genus Leishmania. The clinical
spectrum of leishmaniasis encompasses subclinical ( not apparent), localized (skin lesion), and disseminated (cutaneous, mucocutaneous, and
visceral) infection. This spectrum of manifestations depends on the immune status of the host, on the parasite, and on immunoinflammatory
responses. Visceral leishmaniasis causes high morbidity and mortality in the developing world. Reliable laboratory methods become
mandatory for accurate diagnosis, especially in immunocompromised patients such as those infected with HIV. In this article, we review the
current state of the diagnostic tools for leishmaniasis, especially the serological test.